Delivery Order SPE2DB22D3016-SPE2DB24FBDW5

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $5,273.63 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of a pharmaceutical product, Fluticasone-Salmeterol 115-21 12GM. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including prescription drugs and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,773.62 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Fluticasone-Salmeterol 500-50 60s medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to supply a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to...
The U.S. Defense Logistics Agency (DLA) awarded a $7,648.67 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of Fluticasone-Salmeterol 115-21 12GM pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 between Amerisourcebergen and DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of essential...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,372.95 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,564,590,859 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This is a $9,940.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, with a period of performance through July 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at...
This is a $7,991.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of fluticasone-salmeterol 115-21 inhalation medication in 12 gram quantities. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) awarded a $20,264.02 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication. The contract has an ultimate completion date of September 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government...
This is a $5,457.88 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the supply of FLUTICASONE-SALMETEROL 230-21 12GM, a medication, with a period of performance through June 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a comprehensive...
The U.S. government awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide fluticasone-salmeterol 45-21 12GM medical supplies. The $4,293.61 firm-fixed-price contract has an ultimate completion date of August 13, 2024 and was awarded on August 12, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a medical product. The $4,855.92 firm fixed-price contract has an ultimate completion date of April 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBDW5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $5,454.01 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a prescription medication product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of August 14, 2024 and does not have a set-aside designation.

Generated 11/12/24, 9:01 AM